|
Terumo medical corporation received the following information: it was reported that an angio-seal device was used on the patient and had to be hospitalized later with a grapefruit size hematoma and potentially a pseudoaneurysm.The procedure and angio-seal insertion occurred on (b)(6), 2026.On (b)(6), 2026, the patient was transported to the hospital after walking and feeling a pop at the access site, followed by severe pain and swelling approximately the size of a grapefruit.The patient was admitted for application of a pressure dressing and consultation with vascular surgery.Prior to closure with the angio-seal device, the patient underwent a prostatic artery embolization (pae) procedure.No difficulties were noted with arterial access, sheath placement, guidewire, or catheter insertion in the operative note.A pre-deployment angiogram was not confirmed.Computed tomography (ct) images from the pae procedure.No difficulties were documented in the operative note regarding insertion, deployment, or withdrawal of the device.The patient was hospitalized overnight and required a pressure bandage and vascular surgery consultation.At this time, no further surgical intervention is required.The estimated blood loss was less than 250ml.The patient was admitted on (b)(6), 2026, and discharged the following day, (b)(6), 2026, in stable condition.During the post-operative call on (b)(6), 2026, the patient reported tenderness, moderate swelling, and bruising at the access site.
|
|
A1: patient identifier: requested, not provided
d6b: explanted date: the device was not explanted
e3: occupation: ir nurse manager
the actual device was not available; therefore, the actual device will not be returned for evaluation.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.
|